Prostate Flashcards

(28 cards)

1
Q

Most important risk factors associated with prostate cancer?

A

Age, race and positive family history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What mutation is associated with positive family history and young age for prostate cancer?

A

HOXB13

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the subtypes of prostate cancer?

A
adenocarcinoma (95%)
mucinous adenocarcinoma
small cell
large cell
sarcomatoid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Prostate cancer stage is based on what 3 factors?

A

TNM stage
PSA
Gleason Score

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the two main categories of prostate cancer?

A

Localized and Metastatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are t stages for prostate cancer?

A
T1: no appreciated on exam or imaging
T2: confined to prostate 
-T2a: 50% 1 lobe, 
-T2c: both lobes
T3: outside prostate (T3b: seminal vesicle involvement)
T4: into adjacent tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Most important T stage, Gleason Score and PSA? Why?

A

T2B, 7, 10-20; helps determine Intermediate risk

Low is Int

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are treatment options for localized prostate cancer?

A

Surgery, RT or watchful waiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which risk group is appropriate for watchful waiting?

A

Low risk (Gleason

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When after prostatectomy do you immediately give ADT? Data?

A

Node positive disease; Messing et al, significant improvement in PFS and OS at 11.9 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Who gets ADT with RT for localized disease? And for how long?

A

Intermediate risk: 3-4 months
High risk: 2-3 years
Clinical node positive or T3: indefinite (would recommend surgery here)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are side effects of ADT?

A
hot flashes
fatigue
loss of libido
impotence
weight gain
loss of bone density (can start as early as 6 months)
reduced lean mass
increased LDL, reduced HDL, increased Triglycerides
reduced insulin sensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What should be done to minimize bone loss?

A
Dexa scan at start and regular intervals
calcium (>1200 mg/d)
vitamin D (>800 IU/d)
aerobic/ resistance exercises
smoking cessation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When are bisphosphonates prescribed for prostate cancer? Why?

A

Only in castrate resistant setting

  • prevents skeletal related events (RT to bone, fracture, cord compression or surgery to bone)
    • otherwise only given for therapy in patients with severe osteopenia or porosis (T score > 2.0)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Is cardiovascular-related mortality increased due to prolonged ADT therapy?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When after prostatectomy do you do radiation? What are common adverse effects?

A

positive surgical margins
extracapsular extension
involvement of seminal vesicles or pT3
- rectal, uretheral strictures and incontinence

17
Q

What is PSA level post-prostatectomy for biochemical recurrence?

A

> 0.2 x 2 with no evidence of metastatic disease

18
Q

Why is biochemical recurrence difficult to assess post-RT?

A

there may be residual prostatic tissue; nadir may take up to a year; usually considered significant for biochemical recurrence if 2ng/mL above nadir

19
Q

What is PSA cut-off by ASTRO for salvage RT in localized prostate cancer?

20
Q

For metastatic prostate cancer at presentation, if low volume, what is initial tx option and when is PSA measurement predictive of prognosis?

A
androgen blockade ( mono or dual )
7 months predicts medial survival
-PSA>4 = 13 months
-PSA 0.2-4 = 44 months
-PSA
21
Q

What should you always check before determining someone has castrate-resistant prostate cancer? (2 things)

A

-Testosterone,

22
Q

When can intermittent hormone blockade be used?

A

only localized disease with biochemical recurrence

23
Q

When must continuous hormone blockade be used?

A

metastatic disease (SWOG 9346, Hussain, NEJM 2013)

24
Q

When should chemotherapy be used for metastatic cancer as first line therapy?

A

high volume of disease

  • visceral metastasis
  • 4 or more bone lesions (1 beyond pelvis & axial skeleton)
  • median OS 57.6 months versus 44 months, HR 0.61, P=0.003, CHAARTED, E3805 trial)
25
What must consider for rapid disease progression, especially if visceral metastasis with low PSA rise?
small cell conversion
26
What are advanced androgen blockade agents? Their mechanism of action? In what setting can the be used?
Abiraterone = irreverisble inhibitor of CYP-17A (HTN, LE edema & LFT rise) Enzalutammide = binds androgen receptor and prevents nuclear translocation (fatigue, diarrhea, hot flashes, seizures) - both in pre-docetaxel and post-docetaxel
27
What immunotherapy is approved for metastatic castrate resistant prostate cancer?
Sipuleucal T for asymptomatic or minimally | - median OS 25.8 versus 21.7 months (IMPACT trial)
28
When is Radium-223 given in prostate cancer? How does it work?
alpha emitter and calcium mimetic | - pretreated or unfit for docetaxel with symptomatic bony disease